Table 2 Mean differences between intervention and control groups
Post-intervention (T1) | 3 months follow-up (T2) | |||||
|---|---|---|---|---|---|---|
Mean differences | 95% CI | p | Mean differences | 95% CI | p | |
Quality of life | ||||||
Index value | −0.19 | (−0.33- -0.04) | .02 | −0.21 | (−0.37- -0.05) | .01 |
EQ-5D VAS | −9.1 | (−23.58–5.39) | .21 | −4.3 | (−15.22–6.63) | .43 |
Frailty | ||||||
DFS Men | −1.19 | (−3.46–1.09) | .24 | 0.1 | (−2.16–2.36) | .91 |
DFS Women | −1.22 | (−1.96- -0.48) | .00 | −0.82 | (−1.54- -0.10) | .03 |
VAS pain | 22.12 | (4.18–40.06) | .02 | 13.49 | (−4.09–31.07) | .13 |
SPPB | 0.29 | (−1.17–1.15) | .69 | 0.39 | (−1.23–2.00) | .62 |
Yesavage | −0.12 | (−1.18–0.93) | .82 | −0.28 | (−1.13–0.58) | .51 |
Barthel | −0.27 | (−2.55–2.00) | .81 | −1.65 | (−5.06–1.76) | .33 |